JPRN-UMIN000036706已完成未知
Immune checkpoint inhibitor versus chemotherapy for elderly non-small cell lung cancer:a meta-analysis - ICI for elderly NSCLC
Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine0 个研究点目标入组 1,920 人开始时间: 2019年5月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,920
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with non-small cell lung cancer aged less than 65 years.
研究者
相似试验
进行中（未招募）
1 期
Stereotactic Body Radiation in combination with immunotherapy-chemotherapy in patients with Metastatic Non-Small Cell Lung Cancer.Patients with both squamous and nonsquamous metastatic non-small cell lung cancer (NSCLC) wild type in EGFR, KRAS, ALK and ROS1.MedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-002453-28-ITAZIENDA OSPEDALIERA ARCISPEDALE SANTA MARIA NUOVA/IRCCS DI REGGIO EMILIA132
招募中
不适用
Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung CancerNon Small Cell Lung CancerNCT05059951Hunan Province Tumor Hospital15,000
尚未招募
不适用
Treatment of cancer with Immune Checkpoint Inhibition therapy boosted by High-Intensity Focused Ultrasound Histotripsy; the iFOCUS study.malignancy10027655cancerNL-OMON56837niversitair Medisch Centrum Utrecht24
尚未招募
Unknown
Immune checkpoint inhibitor therapy for advanced, recurrent or metastatic non-small cell lung cancer with low or negative PD-L1 expression.JPRN-UMIN000050723Kobe University200
已完成
不适用
Efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer other than adenocarcinoma or squamous cell carcinoma: multicenter retrospective observational studyon-small cell lung cancer other than adenocarcinoma or squamous cell carcinomaJPRN-UMIN000037777Hamamatsu University School of Medicine60